This is a targeted therapy containing alpelisib. Oncologists prescribe Piqray 150mg Tablet for advanced breast cancer with HR-positive & HER2-negative in patients with a specific PIK3CA mutation. It is taken daily in combination with Fulvestrant. Visit Globans Pharma to know more about the medicine.
Visit: https://www.globanspharma.com/products/piqray-150mg-tablet